Biobeat
Biobeat is a global leader in wearable remote patient monitoring technology, revolutionizing hypertension diagnosis and management through innovative, non-invasive, cuff-less blood pressure monitoring systems. Their mission is to ensure all hypertension patients are monitored and managed effectively, empowering healthcare providers with accurate, real-time data to optimize patient care. Biobeat leverages proprietary patented PPG sensor technology and advanced data analytics to deliver continuous, medical-grade monitoring solutions that enhance clinical decision-making, improve patient compliance, and enable proactive interventions. With FDA-cleared and CE-certified devices, Biobeat is committed to transforming healthcare delivery, supporting both in-hospital and home-based care, and driving better patient outcomes worldwide.
Biobeat
3651 FAU Boulevard, Suite 400, Boca Raton, FL 33431, USA
Biobeat is currently seeking investment
Biobeat is seeking a series-b investment in the range of 5m-20m
Patents
Sensor device for optical measurement of biological properties
2025-01-14 • US-12193811-B2
View DetailsWearable apparatus and method for monitoring medical properties
2023-02-21 • US-11583227-B2
View DetailsSensor device for optical measurement of biological properties
2020-10-27 • US-10813578-B1
View DetailsMethod and device for optical measurement of biological properties
2020-01-21 • US-10537270-B2
View DetailsWhat We Do
A wireless, non-invasive, medical-grade, FDA-cleared chest patch for continuous 24-hour blood pressure monitoring. The device provides accurate, cuff-less measurements, improves patient comfort and compliance, and automatically generates detailed reports for clinicians.
A wearable wrist monitor designed for repeated use, with up to 5 days of battery life. It pairs with the Biobeat app to upload data to the cloud and features internal memory for data storage when offline. Measures multiple vital signs continuously and non-invasively.
A cloud-based platform for real-time patient data management, smart alerting, customizable thresholds, department dashboards, historical data visualization, and automated report generation. Accessible from any web platform and integrates with hospital EMR systems.
Biobeat provides a comprehensive remote patient monitoring platform that enables real-time digital capture and electronic transmission of vital health data from patient to healthcare provider. The platform includes an early warning score system, customizable thresholds, and AI-driven insights for proactive care.
Biobeat's hospital at home solution enables medical-grade monitoring of patients outside the hospital, supporting post-discharge monitoring, home-hospitalizations, and remote patient management. The platform is compatible with both wrist and chest monitors, integrates with mobile apps, and provides customizable alerts and comprehensive data for clinical decision-making.
Biobeat offers in-hospital monitoring using wearable chest patches that track multiple vital signs and parameters. The system connects to a secure, cloud-based management platform, providing real-time data, automated early warning scores, and seamless integration with hospital EMR systems.
Psychological and Cognitive Health and Performance
Diagnostics
Key People
News & Updates
Biobeat's chest patch is FDA-cleared for 24-hour, cuff-less, wireless, non-invasive blood pressure monitoring, marking a significant regulatory milestone.
Biobeat's devices are CE certified, enabling their use in European markets and demonstrating compliance with international safety standards.
Biobeat achieved MDSAP certification, reflecting adherence to global medical device regulatory requirements.
An in-depth look at how Biobeat's cuffless ABPM kit is improving patient comfort, compliance, and clinical outcomes in hypertension management.
Explores the implementation and benefits of continuous monitoring in hospital-at-home programs using Biobeat technology.
Discusses the role of AI and machine learning in advancing healthcare, with insights into Biobeat's integration of these technologies.